Twitter | Pretraživanje | |
F1000Research
An innovative open access publishing platform offering rapid publication & open peer review, whilst supporting data deposition and sharing. Part of .
10.841
Tweetovi
883
Pratim
21.805
Osobe koje vas prate
Tweetovi
F1000Research 16 h
A race against time – we need therapies that can be rapidly tested to treat patients, while efforts continue. explains the potential of using ACE2-Fc biologic agent (opinion article awaiting )
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Heidi Gardner 16 h
Absolutely delighted to see this paper from my PhD published! Publishing with has been so straightforward. A systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials:
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Ashley Farley 5. velj
In it's critical to share experiences which is why this piece in detailing "Open Science at the Montreal Neurological Institute and Hospital: the buy-in process" is a great read w/important lessons
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Ambrose Agweyu 23 h
is partnering with to host a writing workshop at leading to publication of high-quality abstracts in ! Interested? Submit your abstract TODAY! Deadline 14 Feb. Limited spaces available!
Reply Retweet Označi sa "sviđa mi se"
F1000Research 4. velj
"This is a much-needed survey, I am happy and thankful that the MiRoR team invested their time and expertise in undertaking it" says in her review of this on editors’ perceptions of editorial interventions 👉
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
AMRC 4. velj
A survey shows that 91% of authors using platforms think the publishing process is efficient and 84% of returning authors prefer open peer review to traditional peer review. Check out our very own Open Research platform hosted by F1000
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Andrea Chiarelli 4. velj
Are you interested in ? Read our paper on , which just passed peer review! This was our first experience of open - a burdensome process, for both reviewers and authors, but a rewarding one!
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Sam Abbott 3. velj
Our analysis looking at understanding the duration and size of the spillover event at the start of the outbreak + the impact this has on transmission is now preprinted and awaiting review
Reply Retweet Označi sa "sviđa mi se"
F1000Research 3. velj
Aiding global health efforts against - recommends pursuing ACE2-Fc biologic agent. He explains the potential benefits of using this agent, providing that manufacturing soon starts on an available sequence
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Andrew Deece 3. velj
Odgovor korisniku/ci @RobertLKruse @F1000Research
Goal of global health efforts against 2019-nCoV is to effectively quarantine patients & screen individuals who may be infected to limit spread. Proposal i. Best potential treatment option in RK opinion, ii. Instructions on how to manufacture the therapy for testing in patients.
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Robert Kruse, MD, PhD 31. sij
My article on outbreak is now online: "Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China". Raced to write and revise in one week! Embracing to solve crisis.
Reply Retweet Označi sa "sviđa mi se"
F1000Research 1. velj
Presenting Pathfinder, an open source application for analysing spatial navigation behaviours. In this software tool article published in our gateway, the authors present their simple to use tool for studying navigational strategies 👉
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
INCF 1. velj
The INCF channel on the platform provides an open publishing channel for neuroinformatics research, with immediate publication and transparent peer review. No limitation on article size, type, or perceived impact!
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
ELIXIR Europe 31. sij
What types of are appropriate when it comes to ? Does a model that works for apply to ? Read our latest position paper to find out more:
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
F1000 31. sij
How can libraries and funders drive APC transparency? In our most recent webinar we were lucky enough to be joined by from the , to answer this question and to touch on her experience of working at a major research funder 👉
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
Robert Kruse, MD, PhD 31. sij
Special thanks to the team for working with me to expedite publishing this past week to reach the research community quickly, important in this outbreak scenario.
Reply Retweet Označi sa "sviđa mi se"
F1000Research 31. sij
A quick update – Just within 5 days of publishing, this brief report on the has been updated. This is 1 of the benefits of our model, allowing you to rapidly update & improve your research. Version 2 is available now
Reply Retweet Označi sa "sviđa mi se"
F1000Research proslijedio/la je tweet
HRB Open Research 31. sij
We said would be a game changer for Ireland, & now take a look at this – the platform is indexed in Pubmed central! This will increase the visibility of all the platform articles indexed on .
Reply Retweet Označi sa "sviđa mi se"
F1000Research 31. sij
Peer review may feel like it has been around forever, but do you know how it all began? For a potted history of and 's place within it, read this blog by Yousuf Al-Mousawi, Senior Editorial Assistant 👉
Reply Retweet Označi sa "sviđa mi se"
F1000Research 31. sij
Odgovor korisniku/ci @F1000Research
The Coronavirus Gateway area on provides a platform for rapid dissemination of the latest research related to Coronavirus, making the information publicly available so that others can respond effectively
Reply Retweet Označi sa "sviđa mi se"